Dapsone in Saliva and Plasma of Man
Authors:
- J.H. PetersJPJ.H. Peters
- Jr. J.F. MurrayJMJr. J.F. Murray
- G.R. GordonGGG.R. Gordon
- R.H. GelberRGR.H. Gelber
- 1 January 1981
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 22 (3) , 162-171
Abstract
Concentrations of dapsone (DDS) and its metabolite, monoacetyl dapsone (MADDS) were measured in plasma and saliva samples collected concurrently from volunteers receiving a 50-mg oral dose of DDS. A liquid chromatographic technique was employed to separate the compounds from each other and from endogenous materials. Fluorescence detection provided limit sensitivities to 0.1 ng/ml of sample. Saliva levels of DDS were consistently 15–20% of the plasma levels of DDS during the study period, which ranged from 4 to 48 h. Decay rates for DDS from saliva and plasma were nearly identical. In 4-hour samples of plasma subjected to equilibrium dialysis, we found amounts of DDS in the dialysates nearly identical to levels found in saliva collected at that time. Saliva levels of MADDS ranged from 0.8 to 2.6% of their plasma levels at all times. Decay rates of MADDS from the two fluids were nearly identical and saliva levels of MADDS in 4-hour samples were nearly identical to levels found in paired plasma dialysates. Nevertheless, levels of MADDS were so low that a reliable definition of the subjects’ acetylator phenotype from levels of MADDS in saliva only was impossible.Keywords
This publication has 3 references indexed in Scilit:
- Use of saliva in therapeutic drug monitoring.Clinical Chemistry, 1977
- Acedapsone Treatment of Leprosy Patients: Response versus Drug Disposition *The American Journal of Tropical Medicine and Hygiene, 1977
- Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring.Clinical Chemistry, 1976